Dear Acta Cardiologica Sinica,
Regarding the errors in our published article "Taiwan Consensus for the Management of Cardiovascular Risks and Complications in Patients with Prostate Cancer" in volume 41 number 3 May 2025 (doi:10.6515/ACS.202505_41(3).20250224A)
The original version of this article unfortunately contained the following errors, for which we respectfully request corrections. The errors regarding the author name, typos in Figure 2, manuscript on Page 297 and 301 and duplicated references were due to unintentional oversight during manuscript preparation. We sincerely apologize for the mistakes and kindly request correction in the published version.
1. The co-first author’s name "Jiang-Huang Hong" should be corrected to "Jian-Hua Hong".
2. In Figure 2, "LHTH" should be corrected to "LHRH" in the flow chart.
3. On Page 297 and Page 301, "ABCDE" approach (Awareness, Blood pressure, Cholesterol, Diabetes/Diet, Exercise)" should be changed to "ABCDE" approach (Awareness, Blood pressure, Cholesterol/Cigarette, Diabetes/Diet, Exercise)"
4. Duplicates in References:
no. 21 and no. 133 → Reference no. 133 should be removed.
no. 17 and no. 125 → Reference no. 17 should be replaced with the following:
"Tisseverasinghe S, Tolba M, Saad F, et al. Should prostate cancer patients with history of cardiovascular events be preferentially treated with luteinizing hormone-releasing hormone antagonists? J Clin Oncol 2022;40:4173-7."